We have used the yeast two-hybrid system to isolate cDNAs encoding proteins that specifically interact with the 42-aa ␤-amyloid peptide (A␤), a major constituent of senile plaques in Alzheimer's disease. The carboxy terminus of ␣ 2 -macroglobulin (␣2M), a proteinase inhibitor released in response to inf lammatory stimuli, was identified as a strong and specific interactor of A␤, utilizing this system. Direct evidence for this interaction was obtained by co-immunoprecipitation of ␣2M with A␤ from the yeast cell, and by formation of SDS-resistant A␤ complexes in polyacrylamide gels by using synthetic A␤ and purified ␣2M. The association of A␤ with ␣2M and various purified amyloid binding proteins was assessed by employing a method measuring proteinprotein interactions in liquid phase. The dissociation constant by this technique for the ␣2M-A␤ association using labeled purified proteins was measured (K d ‫؍‬ 350 nM). Electron microscopy showed that a 1:8 ratio of ␣2M to A␤ prevented fibril formation in solution; the same ratio to A␤ of another acute phase protein, ␣ 1 -antichymotrypsin, was not active in preventing fibril formation in vitro. These results were corroborated by data obtained from an in vitro aggregation assay employing Thiof lavine T. The interaction of ␣2M with A␤ suggests new pathway(s) for the clearance of the soluble amyloid peptide.
Senile plaques in the brain and cerebral blood vessels of patients with Alzheimer's disease are composed primarily of the aggregated form of A␤ (1, 2) . The A␤ peptide is derived post-translationally by proteolytic activity from a larger amyloid precursor protein (3) (4) (5) (6) (7) (8) (9) (10) . The mechanism for A␤ clearance or for its deposition is not known. Two proteinase inhibitors, ␣ 2 -macroglobulin (␣2M) and ␣ 1 -antichymotrypsin (␣1ACT), have been identified as being associated with senile plaques (11, 12, 13) . ␣2M is capable of binding to and blocking the proteolytic activity of most proteinases before rapid clearance of these ␣2M -proteinase complexes by the low density lipoprotein receptor-related protein (LRP). Internalization and degradation of ␣1ACT-proteinase complexes are mediated by the serpin-enzyme complex receptor. Significantly increased levels of both ␣2M and ␣1ACT are often found in localized areas of inflammation (14, 15, 16) . The full range of biological activities of ␣2M and ␣1ACT still remains to be defined.
In an effort to identify proteins that interact in vivo with A␤ and therefore might play a role in its clearance or deposition, we screened a HeLa library using the yeast two-hybrid system (17) (18) (19) (20) (21) . One of the proteins determined to have a strong and specific interaction with A␤ was ␣2M. To examine the possible role of this interaction in neurotoxic amyloid fibril formation, we investigated the following: (i) the in vivo binding of A␤ to ␣2M in the yeast cell; (ii) the in vitro binding affinity of A␤ to ␣2M compared with that of A␤ to other amyloid-binding proteins; and (iii) the effect of ␣2M, ␣1ACT, and apolipoprotein (apo) J on fibril formation.
EXPERIMENTAL PROCEDURES
Bacterial and Yeast Strains. Manipulations of bacterial strains and of DNAs were by standard methods (22, 23) .
Construction of Bait and Prey Plasmids. The bait plasmids (LexA-A␤ and LexA-C100 fusion proteins) were constructed as described (17) . The bait plasmid encoding LexA-bicoid fusion protein and the prey plasmids (fusion of B42 to cDNAs from HeLa library; ref. 18) were kindly provided to us by Roger Brent (Massachusetts General Hospital, Boston). The prey fusion proteins were inducible in yeast grown on minimal medium containing 2% galactose and 1% raffinose (Gal͞Raf) but not in yeast grown on 2% Glc. Western blot analyses (24) were performed to show that the bait and prey plasmids expressed the expected fusion proteins (data not presented).
Transformation of Strain with Reporter, Bait, and HeLa Library Prey Plasmids. The selection strain was created by transforming the EGY48 yeast strain with a URA3 lacZ [␤-galactosidase (␤-gal)] reporter plasmid and the HIS3 bait plasmid (22) as described (17) . The yeast selection strain harboring the bait and reporter plasmids was transformed with prey plasmid DNA (22) , and tryptophan utilization phenotype was used for selection of transformants.
Determination of Bait-Prey Interaction. Yeast strains containing the appropriate bait and prey plasmids were grown to OD 600 ϭ 0.5, diluted 1,000-fold, and spotted on plates containing Gal͞Raf Ura ␤-Gal Activity in Liquid Cultures of Yeast. Cells were assayed for ␤-gal activity using the O-nitrophenyl-␤-Dgalactoside method (22) .
Immunoprecipitation and Western Blotting. Preparation of cell extracts, immunoprecipitation, and Western blotting were performed as described (17) . Western analysis of the blotted proteins was performed with enhanced chemiluminescence reagents (Amersham) using the 12CA5 anti-hemagglutinin mAb (25) .
Binding Studies on Polyacrylamide Gels. Purified ␣2M (from human plasma) was obtained from Calbiochem. For the binding studies with purified proteins (Fig. 4) , 0.5 l of a 1 mg͞ml solution of A␤ was incubated overnight with 10 l of a 4 mg͞ml solution of ␣2M. To confirm the A␤ binding site on ␣2M, 100 l of ␣2M solution (4 mg͞ml) was incubated with 2 ml of hydroxylamine for 4 hr at 45°C, dialyzed against distilled water, and lyophilized. The resulting fragments were incubated with A␤ peptide as described above. Electrophoresis was carried out using 4-15% SDS polyacrylamide gels. Immunoblots were developed by using the anti-A␤ antibodies 4G8 and 6E10.
Determination of K d for Interaction with A␤. Labeling of ␣2M and other amyloid binding proteins with TAG-NHS ester was performed as described in the supplier's kit (IGEN, Gaithersburg, MD), and binding was determined using the Origen Analyzer (IGEN). A␤-(1-40) was end-biotinylated by Peninsula Laboratories. The reaction was carried out for 2 hr at room temperature with shaking. The binding was determined at several fixed concentrations of TAG-labeled proteins (from 2 to 100 nM).
Thiof lavine T Assay for A␤ Aggregation. A␤-(1-40) from Bachem was dissolved at a concentration of 10 mg͞ml (2.5 mM) in dimethyl sulfoxide. The stock was diluted to 0.1 mg͞ml (25 M) in PBS and filtered through a 0.2-m filter. The A␤ solution was added to a 96-well plate at 60 l͞well in triplicate along with the test proteins at concentrations ranging from 0 to 1 mM. The plates were incubated with shaking at 37°C. After 4 days, 240 l of 20 M Thioflavine T (in 50 mM potassium phosphate buffer, pH 6.0) was added to each well. Fluorescence was read 30 min later at E x ϭ 450 nm and E m ϭ 482 nm using a Cytofluor II microplate reader (Biosearch, Bedford, MA).
Electron Microscopy. The concentration of A␤-(1-40) was 50 M, and the concentration of each of the test compounds, ␣2M, apoJ, or ␣1ACT, was 6 M. Freshly solubilized A␤ peptide was incubated in PBS, pH 7.4, alone or with test compound at 37°C for four days. Incubations were performed as in ref. 26 . A 5-l portion of the fresh or aggregated A␤ solution was applied to a 200-mesh, carbon formvar-coated copper grid. Excess fluid was blotted, and the grids were allowed to air dry. The grids were stained with 2% uranyl acetate for 5 min, rinsed with distilled water, and blotted dry. Observations were made at different magnifications on a JEOL JEM 100S electron microscope at 80 kV.
RESULTS
Interaction of A␤ with ␣2M. Using the system described by Golemis and Brent (19) , we created a yeast selection strain containing a hybrid gene encoding A␤ 1-42 as a bait fused in frame to the bacterial LexA DNA-binding domain that by itself has no transcriptional activation function in yeast (27) . The host strain contains LEU2 and lacZ reporter genes carrying LexA operators instead of native upstream activating sequences. A strain containing the bait (LexA-A␤) and the reporters (LEU2 and lacZ) remains inert for the expression of leucine utilization or ␤-gal activity unless it also contains a vector (prey) that expresses an interacting protein as a molecule fused to the B42 trans-activation domain (18) . The activation-tagged cDNA-encoded prey proteins are expressed in yeast grown on galactose but not in yeast grown on Glc.
The prey plasmid library (from HeLa cells) was first screened for the ability to grow on medium devoid of leucine. Of the Ϸ4 ϫ 10 6 colonies screened, Ϸ0.1% exhibited growth on this medium. Approximately 30% of these also exhibited a blue color on Gal͞Raf X-Gal medium. The B42-␣2M prey plasmid, when introduced into the yeast strain with LexA-A␤ bait plasmid, produced blue colonies on X-Gal medium and showed growth on minimal medium plates devoid of leucine in the presence of Gal͞Raf as the carbon source but showed no blue-colored colonies and no growth in the absence of leucine with Glc (data not shown). These results indicate that the interaction between LexA-A␤ bait and B42-␣2M prey was triggered by expression of the prey protein under the influence of the GAL1 promoter. When LexA-bicoid and LexA-C100 were used as baits, no interaction was observed irrespective of the carbon source used (data not shown), indicating that the interaction between LexA-A␤ and B42-␣2M is specific. The cDNA for the prey protein described above corresponds to the 250 C-terminal aa of ␣2M (28, 29) (Fig. 1) . The yeast twohybrid screen therefore suggests a strong and specific interaction between A␤ and the carboxy-terminus of ␣2M.
Quantitation of Interaction. To quantitate the observed A␤-␣2M interaction, we used the O-nitrophenyl-␤-Dgalactoside colorimetric assay. The results presented in Fig. 2 indicate that there is significantly higher ␤-gal activity in the yeast strains expressing B42-␣2M prey͞LexA-A␤ bait (strain 1) compared with: (i) yeast cells expressing B42-␣2M prey͞ LexA-bicoid bait (strain 2), (ii) A␤ in the bait plasmid but no prey DNA insert in the B42 plasmid (strain 3), or (iii) no prey DNA linked to B42 and no bait DNA linked to LexA (strain 4), confirming that the observed interaction between A␤ and ␣2M is strong and specific.
Formation of Bait-Prey Complexes. We attempted to obtain direct in vivo evidence for the interaction between B42-␣2M prey and LexA-A␤ bait proteins (␣2M͞A␤ complex) by using anti-A␤ antibodies 4G8 and 6E10. If A␤ (bait) reacts with ␣2M (prey), a bait-prey complex may be coprecipitated with antibodies specific to the bait, and the prey fusion protein may be visualized as a band of 40 kDa on a Western blot using an anti-hemagglutinin antibody to this protein. Indeed, the preyspecific hemagglutinin immunoreactivity for the B42-␣2M fusion protein is observed at 40 kDa from immunoprecipitated extracts obtained from cells grown in the presence of galactose ( Fig. 3 ; lane 1) but not from those obtained from cells grown in Glc (Fig. 3; lane 2) . When cell extracts were subjected directly to immunoblotting (without prior immunoprecipitation) with anti-hemagglutinin antibody, the 40-kDa band was observed from cells grown in the presence of galactose ( Fig. 3 ; lane 3) and not from cells grown in Glc ( Fig. 3; lane 4) . No immunoreactive bands were observed from immonoprecipitates of cells with A␤-LexA bait but no ␣2M insert in the prey plasmid ( Fig. 3 ; lane 5) or from cells containing no inserts in the bait or prey plasmids ( Fig. 3; lane 6) . These results suggest an in vivo interaction between ␣2M and A␤ within the yeast cell.
Binding Between A␤ and Purified ␣2M. When synthetic A␤-(1-40) peptide was mixed with ␣2M purified from human plasma. After SDS͞PAGE and immunoblotting, in addition to the 4-kDa band for A␤, an upshifted band corresponding to the (Fig. 4, lane 3) . These results are in agreement with data of Du et al. (32) . Furthermore, a preparation of purified ␣2M subjected to hydroxylamine treatment (a condition that yields an Ϸ43-kDa C-terminal fragment containing the receptor binding site) followed by mixing with A␤, then SDS͞PAGE and immunoblotting, yielded an Ϸ46-kDa band on immunoblots probed with anti-A␤ antibody (Fig.  4, lane 4) , a result consistent with the binding of A␤ peptide to the C-terminal receptor binding domain of ␣2M. A similar A␤-␣2M complex was obtained when 125 I-labeled A␤ was mixed with the hydroxylamine digestion fragment, followed by SDS͞PAGE and exposure to enhanced chemiluminescence film (data not shown).
To assess the extent of the association between A␤ and ␣2M, we devised a method for determining the binding between two proteins in liquid phase (see Experimental Procedures). Purified native human ␣2M was labeled with an electrochemiluminescent reagent (N-hydroxysuccinimide ester of a ruthenium (II) tris-bipyridine chelate; TAG-NHS ester), and the amino terminus of A␤-(1-40) peptide was labeled with biotin. Increasing concentrations of biotinylated A␤-(1-40) were added to several fixed concentrations of TAG-labeled ␣2M (5.5 nM, 28 nM, and 56 nM), and the electrochemiluminescence produced by the material attached to the streptavidincoated magnetic beads was determined. The binding between A␤ and ␣2M was found to be saturable (Fig. 5) , specific, and reversible. The specificity was ascertained by measuring the binding of both A␤ and ␣2M to a number of known proteins (including BSA; data not shown). The binding between A␤ and ␣2M could be reversed by the addition of increasing quantities of unlabeled A␤ peptide in the reaction mixture (data not shown). A K d of 350 nM was determined for the interaction between A␤ and ␣2M (Table 1 ) in contrast to a K d of 0.38 nM reported by Du et al. (32) for binding between iodinated A␤-(1-42) and ␣2M. These differences may be due to the fact that we use A␤ peptide labeled singly at the N-terminal end with biotin. A K d value of 2 nM has been reported for the A␤-apoJ interaction by Matsubara et al. (33) in contrast to the K d value of 50 nM obtained by the liquid-phase interaction method described here. This difference may be because of the fact that Matsubara et al. (33) used immobilized peptide (apoJ incubated with A␤ 1-40 coated wells) followed by detection by using anti-apoJ antibodies to study the interaction. The relative affinities of the interactions between A␤ and other amyloid binding proteins such as transthyretin, apoE3, apoE4, apoE2, ␣1ACT, anti-A␤ antibody 4G8, and anti-A␤ antibody FCA3340 as determined by this method are listed in Table 1 . Effect on in Vitro A␤ Fibril Formation. Thioflavine T interacts in some unknown way with crossed ␤-sheet structures common to the aggregated amyloid protein (34) (oligomers and various forms of fibrils). We measured the aggregation of A␤ peptide using the Thioflavine T binding assay similar to that described by LeVine et al. (34) . Incubation of a solution containing A␤-(1-40, 25 M) and ␣2M (0-5 M) for 4 days at 37°C demonstrated significant inhibition of the aggregation (Fig. 6) , with an IC 50 of 280 nM. A solution of A␤ incubated with apoJ also demonstrated inhibition of aggregation, with an IC 50 of 120 nM (Fig. 6) . In contrast, a solution of A␤ incubated under the same conditions with ␣1ACT showed no significant inhibition of aggregation of the A␤ peptide (Fig. 6) . Our results point to robust anti-aggregation effects of ␣2M and apoJ; however the data indicate that ␣1ACT has no significant effect on aggregation.
Solutions of A␤ (50 M) in water incubated for 4 days at 37°C in the presence of 6 M ␣2M (ratio Ϸ8:1) showed no A␤ fibril formation (Fig. 7A ) in contrast to the typical fibrils formed as a result of incubating A␤ alone under similar conditions (Fig. 7B) . A solution of apoJ (6 M) incubated with A␤ under these conditions showed a decrease in fibrils formed (Fig. 7C ) compared with a solution of A␤ alone. A solution of A␤ with ␣1ACT (6 M) displayed significant A␤ fibril formation (Fig. 7D ) under similar incubation conditions. As a control, a solution of ␣2M (6 M) was incubated under the same conditions in the absence of A␤. No fibril formation was observed in the electron micrograph for this solution (Fig. 7E ) nor in solutions of apoJ alone or ␣1ACT alone (data not presented).
It is important to note that Thioflavine T method measures ␤-pleated sheet structures, not visible fibrils; therefore the observed differences between stoichiometry of inhibition (Ϸ1:100 ratio of A␤ to ␣2M in Thioflavine T assay vs. 1:8 ratio of A␤ to ␣2M in electron microscopy study) are not surprising. Our data suggest that ␣ 2 M and apoJ are potent inhibitors of amyloid aggregation and fibril formation.
DISCUSSION
The data presented in this paper suggest a strong and specific interaction between A␤ peptide and the last 250 aa of the C-terminal region of ␣2M (Fig. 1) . In this yeast system, no interaction was observed between the last 100 aa of amyloid precursor protein and ␣2M or between Drosophila bicoid protein and A␤ indicating the selectivity and specificity of A␤-␣2M interaction (data not shown). The strength of this interaction was confirmed using the ␤-gal colorimetric assay (Fig. 2) . The protein complexes corresponding to ␣2M and A␤ were directly isolated by immunoprecipitation from yeast cells (Fig. 3) to demonstrate in vivo binding. The interaction between purified ␣2M and A␤ was confirmed on SDSpolyacrylamide gels using labeled A␤ (data not presented) or by using antibodies raised against A␤ peptide (Fig. 4) . The interaction between A␤ and other amyloid-binding proteins was directly measured by utilizing an electrochemiluminescence-based liquid phase interaction assay (described in detail in Experimental Procedures section; Fig. 5 and Table 1 ). This interaction assay indicated that the affinity of interaction between A␤ and ␣2M was comparable to the affinity of interaction between A␤ and transthyretin and between A␤ and apoE2, apoE3, and apoE4. The binding between A␤ and ␣2M was found to be saturable (Fig. 5) , reversible, and specific. Finally, we have shown that ␣2M inhibits the ␤-sheet formation (Fig. 6 ) and fibril-formation (Fig. 7) activities of A␤.
The formation of amyloid fibril requires a chemically discriminating nucleation event. The kinetics of aggregation have been characterized by a delay period during which the solution remains clear followed by nucleation event that leads to a growth phase typified by viscous and turbid solution in which Table 1 ). (1998) insoluble fibrils can be found (35) . The aggregation can therefore be inhibited by influencing the nucleation event. It is therefore not surprising to find that ␣2M and apoJ in spite of having a 1:1 binding stoichiometry inhibit the formation of fibrils at much lower molecular abundance, presumably by decreasing the availability of amyloid monomers that can participate in nucleation events leading to ␤-pleated structures and fibrils. A similar stoichiometry has been reported for inhibition of A␤ peptide fibril-formation by serum amyloid P component (5:1 ratio of A␤ peptide to serum amyloid P) (36) . The stoichiometries of inhibition are different between the electron microscopy analysis and the Thioflavine T assay because the former method relies on visual observation of fibrils whereas the later is a measure of ␤-pleated sheet structures (not all ␤-pleated sheet structures form visible fibrils). The affinities of interaction between A␤ and apoJ and between A␤ and ␣1ACT were found to be approximately 9 to 10 times stronger compared with the affinity of interaction between A␤ and ␣2M (Table 1) . Both ␣2M and apoJ strongly inhibited the formation of ␤-pleated sheet structures (Fig. 6 ) and fibril-formation (Fig. 7) by the A␤ (1-40) peptide, whereas ␣1ACT did not have any effect on these activities. The effect of ␣1ACT on A␤ fibril formation has been described in literature as both inhibition and enhancement (16, 37) . The data presented in Figs. 6 and 7 clearly point to no significant effect of ␣1ACT on the formation of ␤-pleated sheets or of fibrils. Our data also indicate that the strong binding affinity of a protein to A␤ peptide is not predictive of its effects on the aggregation of the amyloid peptide.
Because the association between ␣2M and A␤ is strong and specific, this complex may be internalized by LRP providing for an additional mechanism of A␤ clearance. Low density lipoprotein receptor-related protein (LRP), in addition to being the native receptor for ␣2M, also serves as a major apoE receptor in the central nervous system. The LRP-mediated uptake of apoE͞A␤ complexes may be a mechanism of A␤ clearance from the neuropil (12) . The cellular uptake and subsequent degradation of amyloid precursor protein containing the first 17 amino acids of amyloid peptide also is mediated by LRP (30) . Qiu et al. (31) have reported degradation of A␤ by a Ser protease-␣2M complex. In that case, ␣2M may aid the presentation of the amyloid peptide substrate to the enzyme because this proteolytic activity is associated with the ␣2M-protease complex (rather than protease alone). Recently Narita et al. (36) CNS tissue by facilitating the clearance of ␣2M-bound A␤ peptide. Additional experimentation will be necessary to determine the various mechanisms by which amyloid peptide and its fragments may be internalized by LRP. It has been noted that LRP and all seven known LRP ligands are associated with amyloid plaques. Because these ligands are rapidly internalized and degraded when bound to intact LRP, it has been suggested that LRP may be dysfunctional in AD (12) . That is, aggregates of A␤ in senile plaques may be bound by apoE or ␣2M; LRP then binds but cannot internalize these complexes. Future experiments will be directed toward understanding the mechanisms by which A␤, ␣2M, and apoE isoforms are internalized individually, and in combination, in various cell systems.
